Abbott and GSK to develop molecular diagnostic test for skin cancer treatment March 10, 2010 No Comments
Harvard and Dana-Farber grant Acetylon exclusive license to HDAC inhibitor discovery platform March 10, 2010 No Comments
Biotie and Pfizer to end discovery phase of development of PDE10 inhibitors for schizophrenia March 10, 2010 No Comments
Amarillo Biosciences and Intas sign license agreement for oral interferon to treat influenza March 8, 2010 No Comments
Foamix and Therapeutics collaborate to develop inflammatory skin disease therapies March 5, 2010 No Comments
RSS